Renaissance Technologies (RenTech)'s SGMO Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 0 shares of Sangamo Therapeutics, Inc. (SGMO) worth $0, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 40 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in SGMO, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 3.67 M shares. Largest reduction occurred in Q1 2026, reducing 4.59 M shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Sangamo Therapeutics (SGMO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Sangamo Therapeutics (SGMO) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -3.84 M | Sold Out | 0 | $0.00 |
| Q1 2026 | -4.59 M | Reduce 54.49% | 3.84 M | $0.25 |
| Q4 2025 | -1.75 M | Reduce 17.21% | 8.43 M | $0.42 |
| Q3 2025 | +3.34 M | Add 48.88% | 10.18 M | $0.67 |
| Q2 2025 | +3.67 M | Add 115.88% | 6.84 M | $0.54 |
| Q1 2025 | +83,230 | Add 2.70% | 3.17 M | $0.66 |
| Q4 2024 | -1.77 M | Reduce 36.43% | 3.08 M | $1.02 |
| Q3 2024 | +726,200 | Add 17.60% | 4.85 M | $0.87 |
| Q2 2024 | +1.53 M | Add 58.84% | 4.13 M | $0.36 |
| Q1 2024 | -547,901 | Reduce 17.42% | 2.6 M | $0.67 |
| Q4 2023 | +780,124 | Add 32.98% | 3.15 M | $0.54 |
| Q3 2023 | -701,742 | Reduce 22.88% | 2.37 M | $0.60 |
| Q2 2023 | -165,299 | Reduce 5.11% | 3.07 M | $0.00 |
| Q1 2023 | +1.11 M | Add 52.53% | 3.23 M | $0.00 |
| Q4 2022 | +453,400 | Add 27.21% | 2.12 M | $0.00 |
| Q3 2022 | +226,600 | Add 15.74% | 1.67 M | $4.90 |
| Q2 2022 | +676,400 | Add 88.64% | 1.44 M | $4.14 |
| Q1 2022 | -87,600 | Reduce 10.30% | 763,096 | $5.81 |
| Q4 2021 | +115,196 | Add 15.66% | 850,696 | $7.50 |
| Q3 2021 | +152,300 | Add 26.11% | 735,500 | $9.01 |
| Q2 2021 | -196,600 | Reduce 25.21% | 583,200 | $11.97 |
| Q1 2021 | -512,800 | Reduce 39.67% | 779,800 | $12.53 |
| Q4 2020 | -32,891 | Reduce 2.48% | 1.29 M | $15.60 |
| Q3 2020 | +1.33 M | New Buy | 1.33 M | $9.45 |
| Q4 2019 | -67,000 | Sold Out | 0 | $0.00 |
| Q3 2019 | -559,800 | Reduce 89.31% | 67,000 | $9.04 |
| Q2 2019 | -278,400 | Reduce 30.76% | 626,800 | $10.77 |
| Q1 2019 | +905,200 | New Buy | 905,200 | $9.54 |
| Q1 2018 | -23,800 | Sold Out | 0 | $0.00 |
| Q4 2017 | +23,800 | New Buy | 23,800 | $16.39 |
| Q1 2017 | -321,819 | Sold Out | 0 | $0.00 |
| Q4 2016 | -272,681 | Reduce 45.87% | 321,819 | $3.05 |
| Q3 2016 | +480,300 | Add 420.58% | 594,500 | $4.63 |
| Q2 2016 | -389,864 | Reduce 77.34% | 114,200 | $5.79 |
| Q1 2016 | +294,664 | Add 140.72% | 504,064 | $6.05 |
| Q4 2015 | -276,952 | Reduce 56.94% | 209,400 | $9.13 |
| Q3 2015 | +378,655 | Add 351.59% | 486,352 | $5.64 |
| Q2 2015 | +107,697 | New Buy | 107,697 | $11.09 |
| Q3 2013 | -17,000 | Sold Out | 0 | $0.00 |
| Q2 2013 | +17,000 | Add 0.00% | 17,000 | $7.82 |
Renaissance Technologies (RenTech)'s Sangamo Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Sangamo Therapeutics, Inc. (SGMO) in Q2 2013, acquiring 17,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Sangamo Therapeutics, Inc. (SGMO) for 40 quarters since Q2 2013.
Renaissance Technologies (RenTech)'s largest addition to Sangamo Therapeutics, Inc. (SGMO) was in Q2 2025, adding 6,839,434 shares worth $3.7 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 0 shares of Sangamo Therapeutics, Inc. (SGMO), valued at approximately $0.
As of the Q2 2026 filing, Sangamo Therapeutics, Inc. (SGMO) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Sangamo Therapeutics, Inc. (SGMO) was 10,182,463 shares, as reported at the end of Q3 2025.